Previous 10 | Next 10 |
RANCHO CUCAMONGA, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate Communications, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawa...
Amphastar Pharmaceuticals (AMPH) announced its decision to buy back 26% of the equity of its subsidiary Amphastar Nanjing Pharmaceuticals ((ANP)).Additionally, ANP will spin off its Chinese subsidiary, Nanjing Hanxin Pharmaceutical (Hanxin), and Hanxin’s subsidiaries, the com...
RANCHO CUCAMONGA, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced the restructuring of its Chinese subsidiaries, primarily Amphastar Nanjing Pharmaceuticals Inc. (“ANP”). As part of the restructuring, Amphastar will buyback 26%...
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q1 2021 Earnings Call May 6, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Tra...
Amphastar Pharmaceuticals (AMPH): Q1 Non-GAAP EPS of $0.27 beats by $0.09; GAAP EPS of $0.10.Revenue of $103M (+21.6% Y/Y) beats by $6.13M.Press Release For further details see: Amphastar Pharmaceuticals EPS beats by $0.09, beats on revenue
Reports Net Revenues of $103.0 Million for the Three Months Ended March 31, 2021 RANCHO CUCAMONGA, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”) today reported results for the three ...
Amphastar Pharmaceuticals (AMPH) has announced that the FDA has approved the company’s Abbreviated New Drug Application (“ANDA”) for Morphine Sulfate injection 1mg/mL in the 30mL Pump-Jet Prefilled Syringe System.The injection is indicated for the control of pai...
RANCHO CUCAMONGA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company’s Abbreviated New Drug Application (“ANDA”) for Morphine Sulfa...
RANCHO CUCAMONGA, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its first quarter of 2021 ended March 31, 2021, after the market closes on Thursday, May 6th, 2021, and will hold a conference call...
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event. For further details see: Amphastar Pharmaceuticals (AMPH) Presents At 20th Annual Needham Virtual Healthcare Conference
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...